CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Ibuprofendrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00217191
NCT00217191Phase 4Completed
CompareCT.gov

Ibuprofen and Renal Function in Premature Infants

Maternite Regionale Universitaire·interventional·Posted Sep 22, 2005·Updated Sep 19, 2006

In Brief

A Phase 4 clinical trial evaluating Ibuprofen for Premature Infants and Patent Ductus Arteriosus. Completed, across 3 sites.

Detailed Summary

Purpose of the study: 1. To evaluate renal function maturation within the first month of life in very premature infants. 2. To determine whether a treatment with Ibuprofen for patent ductus arteriosus would alter renal function maturation at short term and up to 28 days of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPremature Infants, Patent Ductus Arteriosus
CountriesFrance
CollaboratorsCentral Hospital, Nancy, France, Ministere de la Sante et de la Protection Sociale, France

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2005
Enrollment StartSep 1, 2004
Study CompletionSep 1, 2006
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Ibuprofendrug